Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Treilleux

Showing results (81-90 of 186) with videos related to

Pageof 19
Sort By:
EMBO Molecular Medicine|July 17, 2023
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα<sup>+</sup> breast cancerCoralie Poulard, Thuy Ha Pham, Youenn Drouet, et al.
Histopathology|March 15, 2018
High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breastGuillaume Bataillon, Laetitia Fuhrmann, Elodie Girard, et al.
Acta Neuropathologica Communications|March 13, 2019
Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitisAude Chefdeville, Isabelle Treilleux, Marie-Eve Mayeur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxelCarlos M Galmarini, Isabelle Treilleux, Fatima Cardoso, et al.
Plos One|October 16, 2009
ADP ribosylation factor like 2 (Arl2) regulates breast tumor aggressivity in immunodeficient miceAnne Beghin, Stéphane Belin, Rouba Hage-Sleiman, et al.
Journal of Neurology|September 4, 2025
Anti-AK5 limbic encephalitis in a patient with pleural mesotheliomaGiulia Sofia Cereda, Antonio Farina, Nolwenn Billet, et al.
Bulletin Du Cancer|August 12, 2023
Jérôme Alexandre, Marie-Aude Le Frère-Belda, Antoine Angelergues, et al.
Cancer Research|October 3, 2012
ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cellsJulien Faget, Nathalie Bendriss-Vermare, Michael Gobert, et al.
Journal of Inflammation Research|May 28, 2021
A Gender-Dependent Molecular Switch of Inflammation via MyD88/Estrogen Receptor-Alpha InteractionRana El Sabeh, Mélanie Bonnet, Katy Le Corf, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervixToyomi Satoh, Yuji Takei, Isabelle Treilleux, et al.
Pageof 19

Showing results (81-90 of 186) with videos related to

Sort By:
Pageof 19
EMBO Molecular Medicine|July 17, 2023
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα<sup>+</sup> breast cancerCoralie Poulard, Thuy Ha Pham, Youenn Drouet, et al.
Histopathology|March 15, 2018
High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breastGuillaume Bataillon, Laetitia Fuhrmann, Elodie Girard, et al.
Acta Neuropathologica Communications|March 13, 2019
Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitisAude Chefdeville, Isabelle Treilleux, Marie-Eve Mayeur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxelCarlos M Galmarini, Isabelle Treilleux, Fatima Cardoso, et al.
Plos One|October 16, 2009
ADP ribosylation factor like 2 (Arl2) regulates breast tumor aggressivity in immunodeficient miceAnne Beghin, Stéphane Belin, Rouba Hage-Sleiman, et al.
Journal of Neurology|September 4, 2025
Anti-AK5 limbic encephalitis in a patient with pleural mesotheliomaGiulia Sofia Cereda, Antonio Farina, Nolwenn Billet, et al.
Bulletin Du Cancer|August 12, 2023
Jérôme Alexandre, Marie-Aude Le Frère-Belda, Antoine Angelergues, et al.
Cancer Research|October 3, 2012
ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cellsJulien Faget, Nathalie Bendriss-Vermare, Michael Gobert, et al.
Journal of Inflammation Research|May 28, 2021
A Gender-Dependent Molecular Switch of Inflammation via MyD88/Estrogen Receptor-Alpha InteractionRana El Sabeh, Mélanie Bonnet, Katy Le Corf, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervixToyomi Satoh, Yuji Takei, Isabelle Treilleux, et al.
Pageof 19